FundedIQ
Health Care

Cureety

Cureety is a telemedicine startup that improves the follow-up and care of patients.

www.cureety.com Dinan, France 11-50 employees
Total raised
$1.2M
Rounds
1
Latest
Apr 2020

Cureety is a telemedicine startup that improves the follow-up and care of patients.

Cureety has raised $1.2M across 1 round. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with plan

1 round on record.

Date
Round
Amount
Lead investor
Apr 1, 2020
$1.2M

Unlock the lead investor and full details for this round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

Cureety is featured in

Similar companies

Dillico

Dillico is a tech company focusing on creating innovative machinery to make the production of mRNA vaccines and medicines more efficient and accessible worldwide.

Seed $8.8M
Parallel 1245

Parallel helps coding agent works side by side with hospital teams to deliver faster and more accurate medical coding.

Seed $3.5M
Fizimed
Series Unknown $4.3M
Circle Safe

Atrial fibrillation is the leading heart rhythm disorder. The best method to avoid it coming back is by undergoing an intervention called ablation. Ablation can be done using Radiofrequency or Cryoballoon, with the latter being a newer, quicker, and simpler technique. However, Cryoballoon ablation carries the risk of causing Diaphragmatic Paralysis. Circle Safe is working on a solution to eradicate this complication entirely.

Series Unknown $8.3M
Lyv

Lyv assists individuals who are experiencing suffering.

Seed $2.7M
Median Technologies

MEDIAN Technologies develops medical imaging software and services dedicated to oncology clinical trials, cancer screening, and clinical practice. The company standardizes and automates the interpretation of medical images in oncology to optimize the diagnosis of cancer patients and the assessment of their response to therapy. The company serves two primary markets: drug development and patient care. MEDIAN Technologies has a strategic partnership with a contract research organization to offer integrated imaging services for clinical trials to biopharma sponsors worldwide, and a strategic partnership with Canon to develop new imaging technologies, and to address the patient care market. MEDIAN Technologies was founded in 2002 and is based in Sophia-Antipolis, France.

Series Unknown $39.3M
Kwit

Kwit creates scientific methods for quitting smoking and provides daily support with positivity and compassion.

Series Unknown $360k
Robeaute

Robeaute is a research and development agency that creates neurosurgical microrobots capable of adjusting to various forms of medical data.

Series A $28.0M
BiPER Therapeutics

A first-in-class pipeline of small compounds aimed at the cancer's overall metabolism is being created by BiPER Therapeutics. The company's main substance, BPR001, is a first-in-class small molecule therapy that targets the oncogenic protein BiP, which has been proven to play a significant role in cancer through the control of endoplasmic reticulum stress.

Series Unknown $840k
CILcare

CILcare specializes in providing drug solutions for hearing and ear disorders.

Series A $22.1M
Jinko

Jinko offers personalized supportive assistance to individuals affected by cancer.

Seed $1.6M
Moria

Moria creates, produces, and sells ophthalmic surgery equipment and instruments for refractive and reconstructive procedures.

Series Unknown $38.8M
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.